Physician

Deepak Mittal, MD

According to 2025 Medicare claims, Deepak Mittal, MD (NPI: 1447296538) practices nephrology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Boone, KY. This provider's primary affiliated billing organization is KIDNEY DISEASE CONSULTANTS (NPI: 1669676383; TIN: 20-8547345) and primary practice location at 41042-1158. Mittal is affiliated with the Healthcare Solutions Network (ACO ID: A3283), participating under the MSSP model.

Mittal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 942 traditional Medicare patients, billed 12,425 HCPCS/CPT codes, and received $885,244 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 4,278 prescription claims across 595 beneficiaries totaling $551,904 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). DME data shows 259 claims. Open Payments data shows 48 records totaling $951. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $551,049 to $885,244. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,068,940 and ending at $551,904. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $26,694 to $17,152.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,015	5,896	$551,049
2016	1,249	7,838	$656,841
2017	1,146	7,795	$662,385
2018	879	4,377	$426,173
2019	897	5,854	$583,451
2020	1,015	6,984	$660,109
2021	982	7,504	$691,936
2022	994	8,849	$749,253
2023	924	10,646	$850,004
2024	942	12,425	$885,244

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	661	19,494	$1,068,940
2016	673	17,479	$949,929
2017	579	5,503	$416,260
2018	491	4,298	$358,189
2019	533	4,020	$512,860
2020	542	3,987	$598,815
2021	583	4,486	$811,801
2022	590	4,353	$739,288
2023	576	4,131	$602,577
2024	595	4,278	$551,904

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	70	363	$39,335
2016	36	181	$20,829
2017	N/R	62	$6,910
2018	N/R	42	$2,984
2019	N/R	42	$442
2020	N/R	12	$154
2021	N/R	58	$1,031
2022	N/R	113	$2,215
2023	18	258	$4,252
2024	17	259	$4,714

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	438	534	$125
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	335	688	$116
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	477	4,530	$87
99239	Hospital discharge day management, more than 30 minutes	354	393	$84
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	148	1,470	$41

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	45	1,890	$158,276
Farxiga	Dapagliflozin Propanediol	68	4,590	$81,627
Repatha Sureclick	Evolocumab	39	1,706	$33,402
Ozempic	Semaglutide	21	952	$24,589
Lokelma	Sodium Zirconium Cyclosilicate	22	892	$22,838

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	N/R	23	$1,081
K0001	Standard wheelchair	Y	N/R	59	$936
E0143	Walker, folding, wheeled, adjustable or fixed height	N	17	17	$717
E0630	Patient lift, hydraulic or mechanical, includes any seat, sling, strap(s) or pad(s)	Y	N/R	13	$549
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	14	$263

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	48	$951	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Deepak Mittal, MD?

Tedicare shows public-source Medicare data for Deepak Mittal, MD (NPI 1447296538), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Deepak Mittal, MD have ACO affiliation data?

Deepak Mittal, MD is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283).

What billing organization is linked to Deepak Mittal, MD?

Deepak Mittal, MD is linked to KIDNEY DISEASE CONSULTANTS (billing NPI 1669676383) in the available physician profile data.

Does Deepak Mittal, MD have Open Payments data?

Deepak Mittal, MD has 48 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.